Cyclosporine-induced pseudoporphyria [4]

Archives of Dermatology

Volumn 139, Issue 10, 2003, Pages 1373-1374

  Hivnor, Chad ^a   Nosauri, Carlos ^a   James, William ^a   Poh Fitzpatrick, Maureen ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

ADULT; BULLOUS DERMATITIS; CASE REPORT; DRUG INDUCED DISEASE; HUMAN; IATROGENIC DISEASE; LETTER; MALE; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; PSEUDOPORPHYRIA; SKIN BIOPSY;

CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PORPHYRIAS; SKIN DISEASES, VESICULOBULLOUS;

EID: 0141995576     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.139.10.1373     Document Type: Letter

References (5)

1. Green JJ, Mander SM. Pseudoporphyria. J Am Acad Dermatol. 2001;44:100-108.
2. Sola R, Puig LL, Ballarin JA, Donate T, del Rio G. Pseudoporphyria cutanea tarda associated with cyclosporine therapy. Transplantation. 1987;43:772.
3. Selzner N, Durand F, Bernuau J, et al. Conversion from cyclosporine to FK506 in adult liver transplant recipients: a combined North American and European experience. Transplantation. 2001;72:1061-1065.
4. Schweizer RT, Meisterling LD. Tolerability of mycophenolate mofetil in organ transplant recipients. Transplant Proc. 2001;33:2309.
5. Schanbacher CF, Vanness ER, Daoud MS, Tefferi A, Su WP. Pseudoporphyria: a clinical and biochemical study of 20 patients. Mayo Clin Proc. 2001;76:488-492.